DC control is important to vitreous flow

Article

The variable duty cycle (DC) control on dual pneumatic ultra high-speed 23G cutters has an important effect on the vitreous flow but this is reduced at high cut rates as a result of convergence, reveals a paper in Retina.

The variable duty cycle (DC) control on dual pneumatic ultra high-speed 23G cutters has an important effect on the vitreous flow but this is reduced at high cut rates as a result of convergence, reveals a paper in Retina.

Dr Bruno Diniz et al., Doheny Eye Institute, Los Angeles, California, USA, used frame-by-frame analysis of high-speed video to determine the DC in core, 50-50 and shave modes. The team used three cutters at various cycles per minute and aspiration levels, mass of water or vitreous removed from a vial was recorded within a certain time period.

For all three modes the DC converged at 5000 cycles per minute and water flow curves followed the DC variation. Vitreous flow rates for all DC modes increased along with the cut rates and peaked at 5000 cycles per minute. Vitreous flow rate independently increased when the DC influence was isolated and aspiration or the cut rate was increased.

Both progressive aspiration value and cut rate, either together or independently, increase the vitreous flow irrespective of the DC. Also, high cut rates reduce the significant effect the DC control has on the vitreous flow.

Please follow this link to read the abstract.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.